Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Denosumab treatment for osteoporosis can cause hair loss.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Steroid hormones can help treat aging issues and improve health in elderly people.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Lactococcus lactis strain H61 may reduce some ageing symptoms.

Testosterone therapy increases bone density in older men with low testosterone levels.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Overexpressing noggin in mice causes severe osteoporosis.

Human hair follicle stem cells can help treat bone loss in osteoporosis.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

A single injection of PTH–CBD can increase bone density for up to a year.

Menopause can cause oral health issues like dry mouth and burning sensations.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.